Moderna to set up commercial organisation in Switzerland EP News Bureau Sep 16, 2020 Appoints Dan Staner as Vice President and General Manager, Switzerland
Why COVID-19 presents a golden opportunity to Indian pharma firms EP News Bureau Sep 16, 2020 Juilee Dandekar, Sector Expert - Healthcare, Business Research & Advisory, Aranca informs that with India Pharma Inc's…
Baricitinib in combination with remdesivir reduces recovery time in hospitalised COVID-19 patients:… EP News Bureau Sep 15, 2020 Data from the Adaptive COVID-19 Treatment Trial (ACTT-2) revealed an approximately one-day reduction in median recovery time for…
Kiadis to collaborate with Abigail Wexner Research Institute for clinical trials of COVID-19 therapy EP News Bureau Sep 14, 2020 The US FDA approved AWRI’s investigational new drug application (IND) for a study in an adult population with off-the-shelf…
Life sciences companies revisiting their EU strategies want to understand the Irish proposition… Lakshmipriya Nair Sep 14, 2020 Tanaz Buhariwalla, India Director IDA Ireland talks about why Ireland is the next ‘speak-to country’ for India, post-Brexit for…
Discord between IMA and MSN Labs over promotion of COVID-19 drug, Favilow Usha Sharma Sep 14, 2020 The doctors’ body claims misuse of its identity in the drug’s promotion while the pharma firm asserts that it has email expressing…
Saptagir Labs signs manufacturing deal with Jubilant Generics for remdesivir EP News Bureau Sep 14, 2020 The drug will be produced at its sterile drug product manufacturing plant in Hyderabad which is WHO GMP certified
Will take first dosage of COVID-19 vaccine if people have trust deficit: Dr Harsh Vardhan EP News Bureau Sep 14, 2020 The Government is considering emergency authorisation of COVID-19 vaccination especially in the case of senior citizens and people…
PNB Vesper gets DCGI nod to test proprietary drug PNB 001 in COVID-19 patients EP News Bureau Sep 11, 2020 A study will be conducted on 40 moderately-ill COVID-19 patients at BMJ Medical College, Pune who are on oxygen support
Only 152 CMOs are equipped to manufacture cell and gene therapies: GlobalData EP News Bureau Sep 11, 2020 Production bottlenecks are the major obstacle to large-scale commercial manufacture once more advanced therapy medicinal products…